---  
layout: startup_page  
title: "ReviR Therapeutics"  
id: "revirtx.com"  
permalink: "/revirtherapeuticsrevirtx.com07262024/"  
website: "https://www.revirtx.com/"  
funding_round: "Series A"  
funding_amount: "$30M"  
investors: "Lapam Capital, CDH Investments, 5Y Capital, Yael Capital, XtalPi, Charcot-Marie Tooth Research Foundation (CMTRF)"  
about: "ReviR Therapeutics is an AI-enabled biotechnology company developing small molecule RNA modulators for neurogenetic diseases. Its VoyageR platform focuses on creating non-invasive, orally administered genetic therapies that regulate RNA splicing and influence protein expression, addressing the limitations of many current genetic therapy modalities. This approach targets 'undruggable' proteins by targeting RNA upstream of protein synthesis."  
markets: "Biotechnology, AI, RNA Therapeutics, Neurodegenerative Diseases, Rare Genetic Disorders"  
hq: "South San Francisco, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/revir-therapeutics"  
twitter: "https://twitter.com/ReVir_Inc"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/revir-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/490180-69"  

date_display: "26-Jul-2024"  
date: "2024-07-26"

# SEO Optimization  
meta_title: "ReviR Therapeutics - Series A Funding ($30M)"  
meta_description: "ReviR Therapeutics, ReviR Therapeutics is an AI-enabled biotechnology company developing small molecule RNA modulators for neurogenetic diseases. Its VoyageR platform foc..."  
meta_keywords: "ReviR Therapeutics, Biotechnology, AI, RNA Therapeutics, Neurodegenerative Diseases, Rare Genetic Disorders, Series A funding"  
canonical_url: "https://startup.projectstartups.com/revirtherapeuticsrevirtx.com07262024/"  
---